JPH01197497A - Production of 2'-alkylidenecytidine derivative - Google Patents
Production of 2'-alkylidenecytidine derivativeInfo
- Publication number
- JPH01197497A JPH01197497A JP63020032A JP2003288A JPH01197497A JP H01197497 A JPH01197497 A JP H01197497A JP 63020032 A JP63020032 A JP 63020032A JP 2003288 A JP2003288 A JP 2003288A JP H01197497 A JPH01197497 A JP H01197497A
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- alkylidene
- formula
- represented
- cytidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はシチジン誘導体からの2′−アルキリデンシチ
ジン誘導体の製造法に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for producing 2'-alkylidene cytidine derivatives from cytidine derivatives.
2′−アルキリデンピリミジンヌクレオシドは、本発明
者らが開発した新規な化合物であり、抗腫瘍剤または抗
ウィルス剤としての開発が期待されているものである(
特願昭62−65405号参照)。2'-Alkylidenepyrimidine nucleoside is a new compound developed by the present inventors, and is expected to be developed as an antitumor or antiviral agent (
(See Japanese Patent Application No. 62-65405).
特願昭62−65405号記載の127−アルキリデン
シチジン誘導体の調製は、ウリジン誘導体を原料化合物
として使用し、■ウィッティッヒ試薬を用いる糖部2−
位のアルキリデン化反応、■糖部3−位および51位水
酸基を保護している保護基の除去反応、および■塩基部
4位のアミノ化反応の各反応工程により構成されていた
。The preparation of the 127-alkylidenecytidine derivative described in Japanese Patent Application No. 62-65405 uses a uridine derivative as a raw material compound, and
The process consisted of the following reaction steps: alkylideneation reaction at the 4-position of the sugar moiety, (2) removal reaction of the protective groups protecting the hydroxyl groups at the 3- and 51st-positions of the sugar moiety, and (2) amination reaction of the 4-position of the base moiety.
しかしながら、上述の従来法は、調製工程が長く、最終
製品の単離収率が低いという問題点を有していた。However, the above-mentioned conventional method has problems in that the preparation process is long and the isolation yield of the final product is low.
本発明者らは、種々の化合物を用いて2′−アルキリデ
ンシチジン誘導体の調製を試みた結果、一般式[II]
〔式中、R1は水素原子、ハロゲン原子または低級アル
キル基、R3はアシル基、R4は水酸基の保護基を示す
、〕で表される化合物を原料化合物として用いれば、2
′−アルキリデンシチジン誘導体を収率よく得ることが
できることを発見して、本発明を完成した。The present inventors tried to prepare 2'-alkylidene cytidine derivatives using various compounds, and as a result, they obtained the general formula [II] [wherein R1 is a hydrogen atom, a halogen atom or a lower alkyl group, and R3 is an acyl group] , R4 represents a hydroxyl group-protecting group] is used as a raw material compound, 2
The present invention was completed by discovering that '-alkylidene cytidine derivatives can be obtained in good yield.
すなわち1本発明は、一般式(1)
〔式中、R1は前記と同意義、R2は水素原子または低
級アルキル基を示す、〕で表される2′−アルキリデン
シチジン誘導体を製造する方法において、上記一般式[
II)で表される原料化合物をウィッテッヒ試薬を用い
るアルキリデン化反応に付し、反応後R3およびR4で
表される保護基を除去して上記一般式(1)で表される
2′−アルキリデンシチジン誘導体を製造する方法(以
下、本発明方法と略称する。)に関するものである。That is, 1 the present invention provides a method for producing a 2'-alkylidene cytidine derivative represented by the general formula (1) [wherein R1 has the same meaning as above and R2 represents a hydrogen atom or a lower alkyl group], The above general formula [
The raw material compound represented by II) is subjected to an alkylidene reaction using a Wittig reagent, and after the reaction, the protecting groups represented by R3 and R4 are removed to obtain 2'-alkylidene cytidine represented by the above general formula (1). This invention relates to a method for producing a derivative (hereinafter abbreviated as the method of the present invention).
以下1本発明の詳細な説明する。The present invention will be explained in detail below.
本発明方法に使用する原料化合物は、前記一般式(II
)で表されるものである(以下、本原料化合物と略称す
ることもある。)。式中、R1のハロゲン原子としては
、ヨウ素、臭素、塩素およびフッ素の各原子を例示する
ことができる。R1およびR2の低級アルキル基として
は、メチル、エチル、プロピル、イソプロピルの炭素数
1〜3のアルキル基を例示することができる。R3のア
シル基としては、アセチル、クロロアセチル、ジクロロ
アセチル、トリクロロアセチル、トリフルオロアセチル
、メトキシアセチル、プロピオニル、n−ブチリル、イ
ソブチリル、(E)−2−メチル−2−ブテノイル、ペ
ンタノイル、ピバロイルなどの脂肪族アシル基、ベンゾ
イル、o−(ジブロモメチル)ベンゾイル、p−フェニ
ルベンゾイル、2,4.6−トリメチルベンゾイル、p
−トルオイル、p−アニソイル、p−ハロベンゾイル、
p−ニトロベンゾイル、p−メトキシベンゾイルなどの
芳香族アシル基を例示することができる。The raw material compound used in the method of the present invention has the general formula (II
) (Hereinafter, it may be abbreviated as the present raw material compound.) In the formula, examples of the halogen atom for R1 include iodine, bromine, chlorine, and fluorine atoms. Examples of lower alkyl groups for R1 and R2 include alkyl groups having 1 to 3 carbon atoms such as methyl, ethyl, propyl, and isopropyl. Examples of the acyl group for R3 include acetyl, chloroacetyl, dichloroacetyl, trichloroacetyl, trifluoroacetyl, methoxyacetyl, propionyl, n-butyryl, isobutyryl, (E)-2-methyl-2-butenoyl, pentanoyl, pivaloyl, etc. Aliphatic acyl group, benzoyl, o-(dibromomethyl)benzoyl, p-phenylbenzoyl, 2,4.6-trimethylbenzoyl, p
-Toluoyl, p-anisoyl, p-halobenzoyl,
Examples include aromatic acyl groups such as p-nitrobenzoyl and p-methoxybenzoyl.
R4の保護基は水酸基の保護基として常用されているも
のであればよく、たとえば、アセチル、プロピオニル、
ブチリル、ベンゾイル、ナフトイルなどのアシル基、エ
チリデン、プロピリデン、イソプロピリデン、ベンジリ
デン、シクロへキシリデン、シクロペンチリデン、メト
キシメチリデン、エトキシメチリデン、ジメトキシメチ
リデンなどのアセタールまたはケタール型保護基、ベン
ジル、P−メトキシベンジル、3,4−ジメトキシベン
ジル、ジフェニルメチル、トリフェニルメチル、αもし
くはβ−ナフチルメチル、α−ナフチルジフェニルメチ
ルなどのアルアルキル基、トリメチルシリル、t−ブチ
ルジメチルシリル、メチルジイソプロピルシリル、トリ
イソプロピルシリル、テトライソプロビルジシロキシル
などのシリル基を例示することができる。The protecting group for R4 may be one commonly used as a protecting group for hydroxyl groups, such as acetyl, propionyl,
Acyl groups such as butyryl, benzoyl, naphthoyl, acetal or ketal type protecting groups such as ethylidene, propylidene, isopropylidene, benzylidene, cyclohexylidene, cyclopentylidene, methoxymethylidene, ethoxymethylidene, dimethoxymethylidene, benzyl, P -Aralkyl groups such as methoxybenzyl, 3,4-dimethoxybenzyl, diphenylmethyl, triphenylmethyl, α- or β-naphthylmethyl, α-naphthyldiphenylmethyl, trimethylsilyl, t-butyldimethylsilyl, methyldiisopropylsilyl, triisopropyl Examples include silyl groups such as silyl and tetraisopropyldisiloxyl.
このような本原料化合物は、たとえば、シチジン誘導体
の塩基部のアミノ基および糖部の3位および5位の水酸
基に保護基を導入し、続いて糖部2位水酸基を酸化反応
に付すことにより調製することができる。該反応工程を
反応式で示せば下記のとおりである。Such a raw material compound can be obtained by, for example, introducing a protecting group into the amino group of the base moiety and the 3- and 5-position hydroxyl groups of the sugar moiety of a cytidine derivative, and then subjecting the 2-position hydroxyl group of the sugar moiety to an oxidation reaction. It can be prepared. The reaction process is shown in the following reaction formula.
〔式中、R1、R3、R4は前記と同意義。〕シチジン
誘導体へのR3およびR4で表される保護基の導入は、
使用した保護基で通常用いられる方法に従って行えばよ
い。たとえば、R3で表されるアシル基の導入は、シチ
ジン誘導体1モルに対して1〜5倍モルのアシル化剤(
R7′に対応する酸の酸無水物または酸塩化物)を用い
て反応溶媒(たとえば、ピリジン、ピコリン、ジエチル
アニリン、ジメチルアミノピリジン、ジメチルホルムア
ミド、アセトニトリル、テトラブチルアミン、トリエチ
ルアミンなどの単独または混合溶媒)中で反応温度O〜
50℃で1〜30時間反応させることにより実施するこ
とができる。また、R4で表される水酸基の保護基の導
入もシリル保護基を例に挙げて説明すれば、シチジン誘
導体1モルに対して1〜3倍モルのシリル化剤を使用し
てアシル化と同様の反応条件にて反応させることにより
実施することができる。[In the formula, R1, R3, and R4 have the same meanings as above. [Introduction of protecting groups represented by R3 and R4 into the cytidine derivative is as follows:
This may be carried out according to a method commonly used for the protecting group used. For example, the introduction of the acyl group represented by R3 is carried out in an amount of 1 to 5 times the mole of the acylating agent (
Acid anhydride or acid chloride of the acid corresponding to R7') is used as a reaction solvent (for example, pyridine, picoline, diethylaniline, dimethylaminopyridine, dimethylformamide, acetonitrile, tetrabutylamine, triethylamine, etc. alone or in combination) In the reaction temperature O~
This can be carried out by reacting at 50°C for 1 to 30 hours. In addition, the introduction of a protecting group for the hydroxyl group represented by R4 can be explained using a silyl protecting group as an example, using a silylating agent in an amount of 1 to 3 times the mole of the cytidine derivative in the same way as acylation. It can be carried out by reacting under the following reaction conditions.
次に、このようにして調製した保護基を有するシチジン
誘導体(化合物(A))を酸化反応に付して本原料化合
物を得る。Next, the cytidine derivative (compound (A)) having a protecting group thus prepared is subjected to an oxidation reaction to obtain the present raw material compound.
化合物(A)の2′位水酸基の酸化方法としては、クロ
ム酸−ビリジン−無水酢酸の複合体などを用いるクロム
酸酸化(A法)、または塩化オキサリル−ジメチルスル
ホキシドなどにより生じる活性化ジメチルスルホキシド
酸化(B法)を用いることができる。酸化反応は、化合
物1モルに対して1〜10倍モルの酸化剤の存在下、A
法の場合には一り0℃〜室温、B法の場合には−10〜
−80℃で1〜10時間反応させることにより実施する
ことができる。Methods for oxidizing the 2'-position hydroxyl group of compound (A) include chromic acid oxidation (method A) using a chromic acid-pyridine-acetic anhydride complex, or activated dimethyl sulfoxide oxidation produced by oxalyl chloride-dimethyl sulfoxide. (Method B) can be used. The oxidation reaction is carried out using A in the presence of an oxidizing agent in an amount of 1 to 10 times the mole of the compound.
In the case of method B, the temperature is 0℃ to room temperature, and in the case of method B, the temperature is -10 to
This can be carried out by reacting at -80°C for 1 to 10 hours.
このようにして調製した本原料化合物は、ヌクレオシド
の通常の単離精製法(たとえば、イオン交換、吸着など
の各種クロマトグラフィー法、再結晶法など)を適宜鳳
隠電■組合わせて単離精製することができる。The raw material compound prepared in this manner is isolated and purified by appropriately combining the usual isolation and purification methods for nucleosides (for example, various chromatography methods such as ion exchange and adsorption, recrystallization method, etc.). can do.
本発明方法は、たとえば上述のようにして調製した本原
料化合物をウィッティッヒ試薬を用いるアルキリデン化
反応に付し、反応後R″およびR4で表される保護基を
除去して2′−アルキリデンシチジン誘導体を得る2′
−アルキリデンシチジン誘導体の製造法に関するもので
ある。In the method of the present invention, for example, the raw material compound prepared as described above is subjected to an alkylidene reaction using a Wittig reagent, and after the reaction, protecting groups represented by R'' and R4 are removed to obtain a 2'-alkylidene cytidine derivative. get 2'
- A method for producing an alkylidene cytidine derivative.
本発明方法に使用することのできるウィッティに
ッヒ試薬は、一般式(c G Hl、 )□P = C
H−側(F?、2
式中、−は前記と同意義。)で表されるアルキリデンホ
スホランであり、具体的にはトリフェニルホスフィンメ
チレン、トリフェニルホスフィンエチレン、トリフェニ
ルホスフィンプロピレンなどを例示することができる。The Witti-Nich reagent that can be used in the method of the present invention has the general formula (c G Hl, )□P = C
It is an alkylidenephosphorane represented by the H- side (F?, 2, where - has the same meaning as above), and specific examples include triphenylphosphine methylene, triphenylphosphine ethylene, triphenylphosphine propylene, etc. can do.
反応に使用するウィッティッヒ試薬は、使用直前に一般
式((CsHs)aP”−CHz171)X−R1
(式中、閣は前記と同意義、X−はBr−、ドなどのハ
ロゲンイオンを示す。)で表されるトリフェニルホスホ
ニウム化合物(たとえば臭化メチルトリフェニルホスホ
ニウム、ヨウ化メチルトリフェニルホスホニムウ、臭化
エチルトリフェニルホスホニウムなど)と強アルカリ(
たとえば、水素化カリウム、水素化ナトリウム、n−ブ
チルリチウム、ナトリウムメトキシド、カリウム−t−
ブトキシド、ナトリウムアミドなど)から常法に従って
調製したものを使用するのが好ましい。ウィッティッヒ
試薬の使用量は本原料化合物1モルに対して1〜3モル
から適宜選定できる。The Wittig reagent used in the reaction is prepared by using the general formula ((CsHs)aP''-CHz171)X-R1 ((CsHs)aP''-CHz171)X-R1 (wherein has the same meaning as above, and X- represents a halogen ion such as Br- or Do). ) (e.g. methyltriphenylphosphonium bromide, methyltriphenylphosphonium iodide, ethyltriphenylphosphonium bromide, etc.) and strong alkalis (
For example, potassium hydride, sodium hydride, n-butyllithium, sodium methoxide, potassium t-
butoxide, sodium amide, etc.) according to a conventional method. The amount of Wittig reagent to be used can be appropriately selected from 1 to 3 moles per mole of the raw material compound.
このようなウィッティッヒ試薬を用いるアルキリデン化
反応は、溶媒(たとえばテトラヒドロフラン、ジオキサ
ン、エーテル、ベンゼン、ジメチルスルホキシドなどの
単独もしくは混合溶媒)中、本原料化合物とウィッティ
ッヒ試薬を反応温度−30〜30℃で0.5〜20時間
反応させることにより実施することができる。Such an alkylidene reaction using a Wittig reagent is carried out by combining the present raw material compound and the Wittig reagent in a solvent (for example, tetrahydrofuran, dioxane, ether, benzene, dimethyl sulfoxide, etc. alone or in a mixed solvent) at a reaction temperature of -30 to 30°C. This can be carried out by reacting for 5 to 20 hours.
また、上記アルキリデン化反応において、反応液中に反
応中間体であるウイッテイツヒ中間体のホスホニウム塩
〔該中間体の構造は明かではないが、その反応様式より
下記に示す構造を有していると考えられる。In addition, in the above alkylidene reaction, a phosphonium salt of the Witteitz intermediate, which is a reaction intermediate, is present in the reaction solution [although the structure of the intermediate is not clear, it is thought to have the structure shown below based on the reaction mode. It will be done.
(式中、R1、R”、R”、R’およびXは前記と同意
義。(In the formula, R1, R'', R'', R' and X have the same meanings as above.
)〕が残存する場合には、必要により上記中間体を反応
溶媒(たとえば、テトラヒドロフラン、ジオキサン、エ
チルエーテル、ベンゼン、ジメチルスルホキシドなどの
単独もしくは混合溶媒)中、強アルカリ(たとえば、水
素化カリウム、水素化ナトリウム、n−ブチルリチウム
、ナトリウムメトキシド、カリウム−t−ブトキシ、ナ
トリウムアミドなど)と反応させて保護基を有する2′
−アルキリデンシチジン誘導体として回収してもよい。)] remains, if necessary, add the above intermediate to a strong alkali (e.g., potassium hydride, hydrogen 2′ with a protecting group
- It may be recovered as an alkylidene cytidine derivative.
かくして調製した保護基を有する2′−アルキリデンシ
チジン誘導体は、必要に応じて上述した本原料化合物と
同様の単離精製手段により単離精製して保護基の除去反
応に供すればよい。The 2'-alkylidene cytidine derivative having a protecting group thus prepared may be isolated and purified, if necessary, by the same isolation and purification means as used for the above-mentioned raw material compound, and then subjected to a reaction for removing the protecting group.
保護基の除去は、使用した保護基において通常用いられ
ている除去法を適宜選択して実施することができる。た
とえば、R3のアシル基の除去は、メタノール−アンモ
ニア(1: 1) 、濃アンモニアなどを用いるアルカ
リ加水分解法により除去することができ R4の水酸基
の保護基としてシリル基を用いた場合にはフッ化アンモ
ニウム処理、酸性もしくはアルカリ性加水分解によりシ
リル基導体は、ヌクレオシドの通常の単離精製手段(吸
着またはイオン交換などの各種クロマトグラフィー法、
再結晶法など)を適宜組合わせて単離精製することがで
きる。Removal of the protecting group can be carried out by appropriately selecting a removal method commonly used for the protecting group used. For example, the acyl group of R3 can be removed by an alkaline hydrolysis method using methanol-ammonia (1:1), concentrated ammonia, etc. When a silyl group is used as a protecting group for the hydroxyl group of R4, fluorine The silyl group conductor can be isolated by ammonium treatment, acidic or alkaline hydrolysis, and the silyl group conductor can be isolated by the usual means of isolation and purification of nucleosides (various chromatographic methods such as adsorption or ion exchange,
Isolation and purification can be carried out by appropriately combining methods (such as recrystallization method).
以下、実施例および参考例を示し、本発明を具体的に説
明する。EXAMPLES Hereinafter, the present invention will be specifically explained with reference to Examples and Reference Examples.
参考例 3’ 、5’ −0−(テトライソプロピルシ
ロキサン−1,3−ジイル)−2′−ケト−4−N−ベ
ンゾイルシチジンの製造
1)3’ 、5’−〇−(テトライソプロピルジシロキ
サン−1,3−ジイル)−4−N−ベンゾイルシチジン
の合成
4−N−ベンゾイルシチジン5g (20,6mmol
)をピリジン50−に溶解させ、これに1゜1.3.3
−ジクロロテトライソプロピルジシロキサン7、1nn
(22,6mmol)を加え、0℃で3時間、続けて
室温で3時間撹拌反応させた。反応後、反応液に氷水を
加えた後溶媒を減圧下留去し、得られた残渣を酢酸エチ
ルに溶解させ、水で3回分配した。有機層を無水硫酸ナ
トリウムで乾燥させた後、溶媒を減圧下留去させた。残
渣をシリカゲルカラム(5X10am)に吸着させ、3
3%酢酸エチル−ヘキサンの混合溶媒で溶出して目的化
合物画分を得、これを減圧下濃縮して3′。Reference example 3',5'-0-(tetraisopropylsiloxane-1,3-diyl)-2'-keto-4-N-benzoylcytidine 1) 3',5'-〇-(tetraisopropyldisiloxane) -1,3-diyl)-4-N-benzoylcytidine synthesis 4-N-benzoylcytidine 5g (20.6mmol
) was dissolved in pyridine 50-, and 1°1.3.3
-dichlorotetraisopropyldisiloxane 7,1nn
(22.6 mmol) was added, and the mixture was stirred and reacted at 0° C. for 3 hours and then at room temperature for 3 hours. After the reaction, ice water was added to the reaction solution, and the solvent was distilled off under reduced pressure. The resulting residue was dissolved in ethyl acetate, and the solution was partitioned three times with water. After drying the organic layer over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. The residue was adsorbed onto a silica gel column (5×10 am) and
Elution with a mixed solvent of 3% ethyl acetate-hexane gave a fraction of the target compound, which was concentrated under reduced pressure to give 3'.
5′−〇−(テトライソプロピルジシロキサン−1,3
−ジイル’)−4−N−ベンゾイルシチジンの非結晶性
粉末7.3g (収率86%)を得た。5'-〇-(tetraisopropyldisiloxane-1,3
7.3 g (yield: 86%) of amorphous powder of -diyl')-4-N-benzoylcytidine was obtained.
元素分析: C,5H43N30. S i ” H2
0として計算値 C:55.32%、H: 7.46%
、N:6.91%剣1リイ直 C:55.54 %、H
ニア、41 %、 N:6. 99 %2)3’ 、
5’ −0−(テトライソプロピルジシロキサン−1,
3−ジイルシン−2′−ケトー4−N−ベンゾイルシチ
ジンの合成
二酸化クロム(Cry、) 5 g (40mmol)
、ピリジン8 、3 mfl (80mmol)およ
び無水酸Wll 5 rnQ(40mn+ol)を塩化
メチレン110mQに混合溶解させてクロム酸コンプレ
ックス溶液を得た。これに3’ 、5’−〇−(テトラ
イソプロピルジシロキサン−1,3−ジイル)−4−N
−ベンゾイルシチジン5.9 g (10mff1ol
)を溶解させて、室温で1時間撹拌反応させた。反応後
、反応液に酢酸エチル500 mQを滴下してシリカゲ
ルカラム(6X1.5C!l)に通液して濾液を得た。Elemental analysis: C,5H43N30. S i ”H2
Calculated value as 0 C: 55.32%, H: 7.46%
, N: 6.91% Sword 1 Lii Direct C: 55.54%, H
Near, 41%, N: 6. 99%2)3',
5'-0-(tetraisopropyldisiloxane-1,
Synthesis of 3-diylcine-2'-keto 4-N-benzoylcytidine Chromium dioxide (Cry) 5 g (40 mmol)
, pyridine 8,3 mfl (80 mmol) and anhydrous acid Wll 5 rnQ (40 mn+ol) were mixed and dissolved in 110 mQ of methylene chloride to obtain a chromic acid complex solution. To this, 3',5'-〇-(tetraisopropyldisiloxane-1,3-diyl)-4-N
-benzoylcytidine 5.9 g (10mff1ol
) was dissolved and reacted with stirring at room temperature for 1 hour. After the reaction, 500 mQ of ethyl acetate was added dropwise to the reaction solution, and the solution was passed through a silica gel column (6×1.5 C!l) to obtain a filtrate.
集めた濾液を減圧上乾固させて、残渣をシリカゲルカラ
ム(3,0X21国)に吸着させ、25%酢酸エチル−
ヘキサンの混合溶媒にて溶出し、酢酸エチル−ヘキサン
から結晶化して3’ 、5’−〇−(テトライソプロピ
ルジシロキサン−1,3−ジイル)−2′−ケト−4−
N−ベンゾイルシチジン4.6g (収率78%)を得
た。The collected filtrate was dried under reduced pressure, and the residue was adsorbed on a silica gel column (3,0 x 21 countries) and 25% ethyl acetate-
It was eluted with a mixed solvent of hexane and crystallized from ethyl acetate-hexane to give 3',5'-〇-(tetraisopropyldisiloxane-1,3-diyl)-2'-keto-4-
4.6 g (yield 78%) of N-benzoylcytidine was obtained.
融点:135〜137℃
元素分析: Cza H4x N□○、S i、として
計算値 C:57.21%、Hニア、03%、Nニア、
15%1す値 C:57.08 %、Hニア、12 %
、Nニア、01 %実施例 12′−デオキシ−2′−
メチリデンシチジン・塩酸塩の製造
1)3’ 、5’ −〇−(テトライソプロピルジシロ
キサン−1,3−ジイル)−2′−デオキシ−2′−メ
チリデン−4−N−ベンゾイルシチジンの合成
臭化メチルトリフェニルホスホニウム10.7g (3
0n+mol)をテトラヒドロフラン60mQに懸濁さ
せ、−20”Cに冷却し、これにn−ブチルリチウム試
液15.8d (25mmol)を滴下して1時間撹拌
反応させた。この溶液にテトラヒドロフラン20mQに
3’ 、5’−0−(テトライソプロピルジシロキサン
−1,3−ジイル)−2′−ケト−4−N−ベンゾイル
シチジン2.9g (5mmol)を溶解させたものを
滴下して一20℃で1時間反応させたのち、室温にもど
してさらに2時間撹拌反応させた。反応後、反応液に1
規定の臭化アンモニウム水溶液50mΩを加え、さらに
酢酸エチルで分配した。分配後、有機層を2回水洗いし
て無水硫酸ナトリウムで乾燥後、溶媒を減圧下留去して
、得られた残液をシリカゲルカラム(2,4X20Q1
1)に吸着させ、25%酢酸エチル−ヘキサンの混合溶
媒で溶出して3’ 、5’ −0−(テトライソプロピ
ルジシロキサン−1,3−ジイル)−2′−デオキシ−
2′−メチリデン−4−N−ベンゾイルシチジンの非結
晶性粉末0.9gを得た。Melting point: 135-137°C Elemental analysis: Calculated value as Cza H4x N□○, Si, C: 57.21%, H near, 03%, N near,
15%1 value C: 57.08%, H near, 12%
, Nia, 01% Example 12'-deoxy-2'-
Production of methylidenecytidine hydrochloride 1) Synthetic odor of 3',5'-〇-(tetraisopropyldisiloxane-1,3-diyl)-2'-deoxy-2'-methylidene-4-N-benzoylcytidine 10.7g (3
0 n + mol) was suspended in 60 mQ of tetrahydrofuran, cooled to -20"C, and 15.8 d (25 mmol) of n-butyllithium test solution was added dropwise thereto, and the reaction was stirred for 1 hour. To this solution, 3' was suspended in 20 mQ of tetrahydrofuran. A solution of 2.9 g (5 mmol) of 5'-0-(tetraisopropyldisiloxane-1,3-diyl)-2'-keto-4-N-benzoylcytidine was added dropwise at -20°C. After reacting for an hour, the temperature was returned to room temperature and the reaction was stirred for an additional 2 hours.After the reaction, 1
A specified aqueous ammonium bromide solution of 50 mΩ was added, and the mixture was further partitioned with ethyl acetate. After the distribution, the organic layer was washed twice with water and dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure.
1) and eluted with a mixed solvent of 25% ethyl acetate-hexane to obtain 3',5'-0-(tetraisopropyldisiloxane-1,3-diyl)-2'-deoxy-
0.9 g of amorphous powder of 2'-methylidene-4-N-benzoylcytidine was obtained.
さらに上記シリカゲルカラムにおいて6.25%エタノ
ール−ジクロロメタンで溶出される両分を集め濃縮乾固
し、得られた残渣をテトラヒドロフラン35nQに溶解
させ、水素化ナトリウムの60%粉末試薬6.1gをア
ルゴン気流下加え、室温で3時間撹拌した。これを上記
と同様に臭化アンモニウム水溶液を加え、酢酸エチル−
水で分配し、さらにシリカゲルカラムで精製して、3′
。Furthermore, both fractions eluted with 6.25% ethanol-dichloromethane in the above silica gel column were collected and concentrated to dryness, the resulting residue was dissolved in 35 nQ of tetrahydrofuran, and 6.1 g of a 60% powder reagent of sodium hydride was added under an argon stream. After addition, the mixture was stirred at room temperature for 3 hours. To this, add ammonium bromide aqueous solution in the same manner as above, and add ethyl acetate.
After partitioning with water and further purifying with a silica gel column, the 3′
.
5′−〇−(テトライソプロピルジシロキサン−1,3
−ジイル)−2′−デオキシ−2′−メチリデン−4−
N−ベンゾイルシチジン1.2g(計2.1g、収率7
2%)の非結晶性粉末を得た。5'-〇-(tetraisopropyldisiloxane-1,3
-diyl)-2'-deoxy-2'-methylidene-4-
N-benzoylcytidine 1.2g (total 2.1g, yield 7
2%) of amorphous powder was obtained.
元素分析: C,、H4,N30GSx2として計算値
C,:59.46%、Hニア、40%、Nニア、17
%期殖C:59.39%、Hニア、52%、Nニア、1
0%2)2′−デオキシ−2′−メチリデン−4−N−
ベンゾイルシチジンの合成
3’ 、5’−0−(テトライソプロピルジシロキサン
−1,3−ジイル)−21−デオキシ−2′−メチリデ
ン−4−N−ベンゾイルシチジン343■(1mmol
)をテトラヒドロフラン10mQに溶解させ、これに1
規定のフッ化トリブチルアンモニウム2.2mfl加え
、0℃で30分間撹拌反応させた1反応液を酢酸で中和
後、溶媒を減圧下留去して得られた残渣をシリカゲルカ
ラム(1,6X30C!l、溶出溶媒=8%エタノール
ークロロホルム)で展開し、エチルエーテル−エタノー
ルから結晶化して2′−デオキシ−2′−メチリデン−
4−N−ベンゾイルシチジン302■(収率88%)を
得た。Elemental analysis: Calculated value as C,, H4, N30GSx2 C,: 59.46%, H near, 40%, N near, 17
% phase growth C: 59.39%, H near, 52%, N near, 1
0%2) 2'-deoxy-2'-methylidene-4-N-
Synthesis of benzoylcytidine 3',5'-0-(tetraisopropyldisiloxane-1,3-diyl)-21-deoxy-2'-methylidene-4-N-benzoylcytidine 343 (1 mmol)
) was dissolved in 10 mQ of tetrahydrofuran, and 1
After adding 2.2 mfl of the specified tributylammonium fluoride and stirring the reaction at 0°C for 30 minutes, the reaction solution was neutralized with acetic acid, the solvent was distilled off under reduced pressure, and the resulting residue was transferred to a silica gel column (1,6X30C! 2'-deoxy-2'-methylidene-
302 ml of 4-N-benzoylcytidine (yield 88%) was obtained.
融点:300℃以上
元素分析:C工、Hl、N、○、として計算値 C:5
9.47%、H:4.99%、N: 12.24%実測
値 C:59.28%、H:5.05%、N: 12.
11%3)2′−デオキシ−2′−メチリデンシチジン
塩酸塩の合成
2′−デオキシ−2′−メチリデン−4−N−ベンゾイ
ルシチジン139 mg (0、5n+mol)をメタ
ノリックアンモニア10−に溶解させ、室温で6時間撹
拌反応させた後、溶媒を減圧下溜去した。Melting point: 300℃ or higher Elemental analysis: Calculated value as C, Hl, N, ○, C: 5
9.47%, H: 4.99%, N: 12.24% Actual value C: 59.28%, H: 5.05%, N: 12.
11% 3) Synthesis of 2'-deoxy-2'-methylidenecytidine hydrochloride Dissolve 139 mg (0.5n+mol) of 2'-deoxy-2'-methylidene-4-N-benzoylcytidine in methanolic ammonia 10- After stirring and reacting at room temperature for 6 hours, the solvent was distilled off under reduced pressure.
残渣をシリカゲルカラム(1,6X10ao、溶出溶媒
=20%エタノールークロロホルム)で展開して目的化
合物画分を集め、これに1規定塩酸を2mQ加え、溶媒
を減圧上留去後、残渣をアセトン−メタノールより結晶
化して2′−デオキシ−2′−メチリデンシチジン11
5■(収率83%)を得た。The residue was developed with a silica gel column (1,6 x 10ao, elution solvent = 20% ethanol-chloroform) to collect the target compound fraction, to which 2 mQ of 1N hydrochloric acid was added, the solvent was distilled off under reduced pressure, and the residue was dissolved in acetone-chloroform. Crystallized from methanol to give 2'-deoxy-2'-methylidenecytidine 11
5■ (yield 83%) was obtained.
本発明方法は、原料化合物として特定のシチジン誘導体
を使用することを特徴とするものであり、従来のウリジ
ン誘導体を原料化合物とする方法と比較して以下に示す
利点を有するものである。The method of the present invention is characterized by using a specific cytidine derivative as a raw material compound, and has the following advantages compared to the conventional method using a uridine derivative as a raw material compound.
■ 本発明方法のアルキリデン化反応に供する原料化合
物が従来と比較して短い反応工程にて調製することが可
能である。(2) The raw material compound to be subjected to the alkylidene reaction of the method of the present invention can be prepared in a shorter reaction step than in the conventional method.
■ 本発明方法は、アルキリデン化反応および保護基の
除去反応の2工程よりなり、従来法で採用されていたア
ミノ化反応を省略することができる。(2) The method of the present invention consists of two steps: an alkylidene reaction and a protecting group removal reaction, and the amination reaction employed in conventional methods can be omitted.
■ ■および■で述べたような反応工程の省略により最
終製品の合成収率を向上せしめることができる。具体的
には、原料化合物である2′−ケトシチジン誘導体から
2′−アルキリデンシチジン誘導体の全体の合成収率は
、本発明方法では53%であるに対して従来法では25
%であり、本発明方法により合成収率を従来法の2倍以
上に向上せしめることが可能となった。(2) By omitting the reaction steps as described in (2) and (2), the synthesis yield of the final product can be improved. Specifically, the overall synthesis yield of a 2'-alkylidene cytidine derivative from a 2'-ketocytidine derivative, which is a raw material compound, is 53% in the method of the present invention, whereas it is 25% in the conventional method.
%, and the method of the present invention makes it possible to improve the synthesis yield by more than twice that of the conventional method.
Claims (1)
ルキル基、R^2は水素原子または低級アルキル基を示
す。〕で表される2′−アルキリデンシチジン誘導体の
製造法であって、一般式〔II〕▲数式、化学式、表等が
あります▼〔II〕 〔式中、R^1は前記と同意義、R^3はアシル保護基
、R^4は水酸基の保護基を示す。〕で表される原料化
合物をウィッティッヒ試薬を用いるアルキリデン化反応
に付し、反応後、R^3、R^4で表される保護基を除
去して上記一般式〔 I 〕で表される2′−アルキリデ
ンシチジン誘導体を得ることを特徴とする2′−アルキ
リデンシチジン誘導体の製造法。 2)ウィッティッヒ試薬が一般式〔III〕 (C_6H_5)_3P=CH−R^2 〔式中、R^2は水素原子または低級アルキル基を示す
。〕で表されるものである請求項1に記載の2′−アル
キリデンシチジン誘導体の製造法。 3)ウィッティッヒ試薬を用いるアルキリデン化反応と
R^3およびR^4で表される保護基の除去反応の間に
さらに強アルカリ処理を行う請求項1に記載の2′−ア
ルキリデンシチジン誘導体の製造法。[Claims] 1) General formula [I] ▲ Numerical formulas, chemical formulas, tables, etc.▼ [I] [In the formula, R^1 is a hydrogen atom, a halogen atom, or a lower alkyl group, and R^2 is a hydrogen atom or a lower alkyl group. ] A method for producing 2'-alkylidene cytidine derivatives represented by the general formula [II] ▲ Numerical formulas, chemical formulas, tables, etc. ▼ [II] [In the formula, R^1 has the same meaning as above, R ^3 represents an acyl protecting group, and R^4 represents a hydroxyl protecting group. ] The raw material compound represented by is subjected to an alkylidene reaction using Wittig reagent, and after the reaction, the protecting groups represented by R^3 and R^4 are removed to obtain 2 represented by the above general formula [I]. A method for producing a 2'-alkylidene cytidine derivative, which comprises obtaining a 2'-alkylidene cytidine derivative. 2) The Wittig reagent has the general formula [III] (C_6H_5)_3P=CH-R^2 [wherein R^2 represents a hydrogen atom or a lower alkyl group]. ] The method for producing a 2'-alkylidene cytidine derivative according to claim 1, which is represented by the following formula. 3) The method for producing a 2'-alkylidene cytidine derivative according to claim 1, wherein a strong alkali treatment is further performed between the alkylidene reaction using a Wittig reagent and the reaction for removing the protecting groups represented by R^3 and R^4. .
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63020032A JPH0633313B2 (en) | 1988-01-30 | 1988-01-30 | Process for producing 2'-alkylidene cytidine derivative |
| KR1019880701498A KR910008800B1 (en) | 1987-03-19 | 1988-03-17 | 2'-alkylidenepyrimidine nucleoside derivatives process for their preparation and their use |
| EP88902560A EP0310673B1 (en) | 1987-03-19 | 1988-03-17 | 2'-alkylidenepyrimidine nucleoside derivatives, process for their preparation, and their use |
| US07/295,948 US5047520A (en) | 1987-03-19 | 1988-03-17 | 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof |
| DE3854110T DE3854110T2 (en) | 1987-03-19 | 1988-03-17 | 2'-ALKYLIDEN-PYRIMIDINE NUCLEOSIDE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE. |
| PCT/JP1988/000278 WO1988007049A1 (en) | 1987-03-19 | 1988-03-17 | 2'-alkylidenepyrimidine nucleoside derivatives, process for their preparation, and their use |
| AT88902560T ATE124702T1 (en) | 1987-03-19 | 1988-03-17 | 2'-ALKYLIDE-PYRIMIDINE NUCLEOSIDE DERIVATIVES, METHOD OF PREPARATION AND USE. |
| CA000583659A CA1319932C (en) | 1988-01-30 | 1988-11-21 | 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof |
| US07/721,828 US5300636A (en) | 1987-03-19 | 1991-06-26 | 2'-alkylidenepyrimidine nucleoside compounds and a process for production of same |
| US08/125,839 US5430139A (en) | 1987-03-19 | 1993-09-24 | 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63020032A JPH0633313B2 (en) | 1988-01-30 | 1988-01-30 | Process for producing 2'-alkylidene cytidine derivative |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5248676A Division JP2511803B2 (en) | 1993-09-09 | 1993-09-09 | Compounds useful for producing 2'-alkylidene cytidine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01197497A true JPH01197497A (en) | 1989-08-09 |
| JPH0633313B2 JPH0633313B2 (en) | 1994-05-02 |
Family
ID=12015727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63020032A Expired - Lifetime JPH0633313B2 (en) | 1987-03-19 | 1988-01-30 | Process for producing 2'-alkylidene cytidine derivative |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPH0633313B2 (en) |
| CA (1) | CA1319932C (en) |
-
1988
- 1988-01-30 JP JP63020032A patent/JPH0633313B2/en not_active Expired - Lifetime
- 1988-11-21 CA CA000583659A patent/CA1319932C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA1319932C (en) | 1993-07-06 |
| JPH0633313B2 (en) | 1994-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4900828A (en) | Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine | |
| US5459254A (en) | Process for preparing synthetic intermediates of 2-alkynyladenosines and 2-alkynyladenosines | |
| US4689404A (en) | Production of cytosine nucleosides | |
| RU2439064C1 (en) | METHOD OF PRODUCING CAPECITABINE AND β-ANOMER RICH TRIALKYLCARBONATE COMPOUND USED THEREIN | |
| Castro-Pichel et al. | A facile synthesis of ascamycin and related analogues | |
| US5625057A (en) | Process for preparing 2',3'-Dideoxy-2',3'-dehydronucleosides | |
| KR20040021670A (en) | Process for the preparation of ribavirin | |
| US5633366A (en) | Pyrimidine nucleoside derivatives and methods for producing them | |
| Perez-Perez et al. | Stereospecific synthesis of branched-chain sugars by a novel aldol-type cyclocondensation | |
| US4945081A (en) | Mycaminosyl tylonolide derivatives | |
| US4751293A (en) | Process for preparation of N6 -substituted 3',5'-cyclic adenosine monophosphate and salt thereof | |
| JPH0615557B2 (en) | 2'-deoxy-2'-methylidene cytidine dihydrate crystal | |
| AU641644B2 (en) | A process for the preparation of etoposides | |
| JP2511803B2 (en) | Compounds useful for producing 2'-alkylidene cytidine derivatives | |
| JPH0633313B2 (en) | Process for producing 2'-alkylidene cytidine derivative | |
| CA2170968A1 (en) | Preparation of d4t from 5-methyluridine | |
| Kondo et al. | Synthesis of Two 3-(7′-Theophyllyl) glycals, 3-Deoxy-3-(7′-theophyllyl)-d-xylo-hex-1-enopyranose and Methyl 3-Deoxy-3-(7′-theophyllyl)-d-xylo-hex-1-enopyranuronate, and their Derivatives | |
| Lubineau et al. | Synthesis of the Sialyloligosaccharide Gal-β (1→ 3)-[Neu5Ac-α (2→ 6)]-GalNAc, The Epitope of the Tumor-Associated Glycoprotein Tag 72 | |
| Garegg et al. | Introduction of 3, 4-unsaturation in 2-amino-2-deoxy-d-glucopyranosides | |
| AU2006325622B2 (en) | A manufacturing process of 2',2'-difluoronucleoside and intermediate | |
| JP2770357B2 (en) | Method for producing nucleoside derivative | |
| JPH09241294A (en) | Production of 2'-deoxy-2'-halocoformycin or its stereoisomer | |
| JPS6092300A (en) | Production of soyasapogenol b derivative | |
| IE67137B1 (en) | 3-Deoxy Mycaminosyl Tylonolide Derivatives | |
| EP0490311B1 (en) | Derivatives of 10,11,12,13-tetra-hydrodesmycosin, processes for preparation, and use thereof in obtaining pharmaceuticals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080502 Year of fee payment: 14 |